Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Joe Copia who wrote (22147)	5/11/2000 1:35:00 PM
From: Joe Copia	Read Replies (1) \| Respond to of 25711

MEHO news ! Thursday May 11, 6:01 am Eastern Time Company Press Release SOURCE: Dermalay Industries, Inc. Dermalay Begins Production of Commercial Spots for National Campaign BEVERLY HILLS, Calif., May 11 /PRNewswire/ -- William Edwards, chief executive officer of Dermalay Industries, Inc. (OTC: DMLY - news), announced today that the company has begun production of several national television commercial spots to promote and sell its PowerHeat(TM) muscle pain relief product. The Oscar award-winning director/producer team of Fincannon and Associates, in conjunction with Ethos Films Inc., has begun filming a 5-minute point-of-purchase video, as well as 30- and 60-second commercials, and testimonial footage featuring several prominent sports celebrities. Slated for June completion, the spots are expected to begin airing in July of this year. The commercials will be an integral part of Dermalay's marketing campaign on a major home shopping channel (to be announced) and will be aired on national cable networks including CNN and ESPN. ``We anticipate that this national exposure will increase sales appreciably in the third and fourth quarters,'' said Edwards. The PowerHeat commercial spots will also include a segment marketing Body Pain Trigger Point(TM) software developed by InterCare.com, a subsidiary of Meridian Holdings, Inc. (OTC Bulletin Board: MEHO - news). Dermalay and Meridian will co-promote the Body Pain Trigger Point software in conjunction with the PowerHeat product in a joint venture that was previously announced. ``Dermalay is fortunate to have such a talented team as Fincannon and Associates deployed on this project. Their track record is impressive, and I am confident that their exceptional creativity and energy will be a tremendous asset as we move forward to develop greater brand recognition and increase sales of our PowerHeat line,'' said Edwards. About Meridian Holdings, Inc. Meridian Holdings, Inc. is an acquisition-oriented holding company focused on building, operating and managing a portfolio of business-to-business companies. Meridian's network of affiliated companies is designed to encourage maximum leverage of information technology, operational excellence, industry expertise and synergistic business opportunity. The company's InterCare.com subsidiary is an FDA-registered software publisher. Visit Meridian's website at www.meho.com and InterCare's website at www.intercare.com. About Dermalay Industries, Inc. Founded in 1995, Dermalay Industries, Inc. is a company on the forefront of developing, manufacturing and distributing emu-oil based products for health and skin care. Visit the company's website at www.dermalay.com. NOTE: Statements contained in this news release that are not purely historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and any amendments thereto. Such statements are made based upon information available to the Company as of the date hereof, and the Company assumes no responsibility to update or revise such forward-looking statements. Editors and investors are cautioned that forward-looking statements invoke risk and uncertainties that may cause the Company's actual results to differ from such forward-looking statements. These include without limitation the Company's ability to expand its market and to continue to finance its operations, economic, competitive, governmental, technological and other factors discussed in the statements and/or in any of the Company's periodic filings with the Securities and Exchange Commission. SOURCE: Dermalay Industries, Inc.